Skip to Main Content
An official website of the United States government

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
Redefining normal: personalized CA125 cutpoints for ovarian cancer screening Kathryn Terry Brigham and Women's Hospital / Harvard Medical School PLCO May 12, 2014 PLCO-82
Reduced rank regression derived dietary patterns and risk of colorectal cancer and mortalit zegeye Abitew Flinders University, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Adelaide, South Australia PLCO Feb 27, 2023 PLCO-1166
Reevaluating the Use of Race and Ethnicity in Medical Risk Assessments Sharad Goel Harvard University NLST Sep 5, 2023 NLST-1121
Reexamine trial outcomes in PLCO to identify interactions of screening effects with screen results and other covariates Hormuzd Katki NCI PLCO Nov 1, 2022 PLCO-1091
Regional CT Parenchymal Abnormalities as Radiographic Biomarkers for Lung Cancer C. Matthew Kinsey University of Vermont College of Medicine NLST Sep 24, 2015 NLST-163
Regions-of-Interest Detection in big histopathological images Li Sulimowicz University of Texas at Arlington NLST Aug 22, 2016 NLST-237
Relationship Among Energy Balance, Health Outcome, and 24-hour Time-Use Lifestyle Behaviors Yaozong He University of Illinois at Urbana-Champaign IDATA Mar 2, 2020 IDATA-34
Relationship between Socioeconomic Status, Obesity and Prevalence of Male Breast Cancer Taye Olabode Walden University PLCO Nov 5, 2021 PLCO-854
Relationship of baseline colonoscopy findings to long term risk of CRC Robert Schoen University of Pittsburgh PLCO Mar 17, 2016 PLCO-199
Relationship of Demographic and Clinical Factors to Free and Total Prostate-Specific Antigen (original title: Free PSA (Patterns of Age and Race Specific Values of Free + Total PSA)) Edward Gelmann Georgetown University PLCO Jul 1, 2006 2006-0106
Relative Survival (excess mortality) of individuals diagnosed with lung cancer in the National Lung Screening Trial. Martin Tammemagi Henry Ford Health System NLST Oct 25, 2011 201110-0019
Relative survival (excess mortality) of individuals diagnosed with lung cancer in the PLCO Trial Martin Tammemagi Brock University / Henry Ford Health System PLCO Feb 2, 2012 2011-0278
Reliability of 24-Hour Dietary Recall for Measuring Meal Timing Mary Playdon University of Utah IDATA Sep 11, 2020 IDATA-40
Renal Cancer and Incidental Findings on Low-Dose CT Paul Pinsky NCI NLST Mar 11, 2015 NLST-126
Repeated measures of metabolomic profiles and pancreatic cancer in PLCO Rachael Solomon DCEG/NCI PLCO Jun 2, 2016 2016-0003
Repeated Measures of Telomere Length and Pancreatic Cancer Shannon Lynch Fox Chase Cancer Center PLCO May 1, 2013 2013-0031
Replication and Comparative Evaluation of Deep Learning Models (Sybil and M3FM) for Lung Cancer Risk Prediction Using NLST Low-Dose CT Scans Aristotelis Tsirigos NYU Langone Health NLST Nov 13, 2025 NLST-1481
Reported Family History of Cancer in the PLCO Trial Paul Pinsky NCI, DCP, EDRG PLCO Jul 1, 2006 2006-0216
Reproducibility and external validation of epidemiological risk models for endometrial cancer Aline Talhouk Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada PLCO Dec 13, 2021 PLCO-878
REPRODUCIBILITY OF PHYSICAL ACTIVITY MEASURES IN ADULTS AND IMPLICATIONS FOR EPIDEMIOLOGICAL STUDIES Pedro Saint-Maurice NCI IDATA Jun 7, 2017 IDATA-12